Romero-Duarte, AlvaroRivera-Izquierdo, MarioJesus Lainez-Ramos-Bossini, AntonioRedruello-Guerrero, PabloCardenas-Cruz, Antonio2023-05-032023-05-032022-05-06Álvaro Romero-duarte, Mario Rivera-izquierdo, Antonio Jesús Láinez-ramos-bossini, Pablo Redruello-guerrero, Antonio Cárdenas-cruz. Factors associated with readmission to the Emergency Department in a cohort of COVID-19 hospitalized patients. Signa Vitae. 2022. 18(1);47-54.1334-5605http://hdl.handle.net/10668/21780Introduction: The aim of this study was to describe the symptomatology and main factors associated with readmission to the Emergency Department (ED) in COVID-19 patients discharged from hospital during the first wave of the pandemic at the San Cecilio University Hospital, Granada. Spain.Methods: An observational longitudinal study was conducted in a cohort of 441 patients admitted to our hospital with confirmed SARS-CoV-2 pob merase chain reaction (PCR) from 1 March to 15 April 2020. Patients were followed up through medical records 6 months after discharge. Sociodemographic, clinical and symptomatologic variables were collected. Descriptive. bivariate and multivariate logistic regression analyses were performed.Results: The mean age of patients in the cohort was 66.4 years (s = 15.3), with 55.1% men. In-hospital mortality was 18.1% The presence of persistent symptomatology was high (64.5%), especially respiratory (53.2%), systemic (46.3%) and neurological (31.0%). A total of 75 (20.8%) patients were readmitted to the ED during the 6 months following hospital discharge. The main factors associated with readmission to the ED were polymedication (P = 0.031), living in a care home (P = 0.014), fever (P = 0.047). general malaise (PenAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/COVID-19SymptomsEmergencyHospitalizationPost-dischargeCoronavirusPatient DischargeSARS-CoV-2Hospital MortalityPolypharmacyPolymerase Chain ReactionHypotensionPatient Readmissionresearch articleopen accessHipotensiónMortalidad HospitalariaReacción en Cadena de la PolimerasaSARS-CoV-2Readmisión del Paciente10.22514/sv.2021.1061845-206Xhttps://oss.signavitae.com/mre-signavitae/article/20220107-49/pdf/SV2021041201.pdf742398900004